IP Library Granted Patent US 7,642,358
Granted Patent B2
US 7,642,358 · App. 11/326,616 · Granted Jan 5, 2010

Substituted phenylacetic acids

Assignee: Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,642,358
App. No.
11/326,616
Granted
Jan 5, 2010
Kind
B2
Abstract

Substituted phenylacetic acids, phenylethanols and related compounds are provided that are useful in treating or controlling a number of diseases associated with glucose metabolism, lipid metabolism and insulin secretion.

Claims (37)

1. A compound of the formula selected from the group consisting of:

wherein

X is a member selected from the group consisting of O, S, SO, SO 2 and NR, wherein R is H, (C 1 -C 8 )alkyl, COR a , COOR a and CONR a R b wherein R a and R b are each independently selected from the group consisting of H and (C 1 -C 8 )alkyl;

Y is a member selected from the group consisting of CH 2 OR c , CO 2 R c , CHO, CONR c R m , CH(═NR c ), CH(═NOR c ), C(O)NHSO 2 R n , tetrazol-5-yl, triazole, hydroxypyrazole, and hydroxyoxazole, wherein R c is a member selected from the group consisting of H, (C 1 -C 8 )alkyl, (C 3 -C 8 )alkenyl, (C 3 -C 8 )alkynyl, (C 3 -C 7 )cycloalkyl, (C 4 -C 8 ) cycloalkyl-alkyl, aryl, aryl(C 1 -C 8 )alkyl and (C 1 -C 8 )alkylene-Z, wherein Z is selected from the group consisting of COR d , COOR d , NR d R e , NR d CONR e R f , NR d COR e , NR d COOR e and CONR d R e wherein R d , R e and R f are each independently selected from the group consisting of H, (C 1 -C 8 )alkyl and phenyl, or optionally two of R d , R e and R f when attached to the same nitrogen atom are combined to form a five- or six-membered ring; and wherein R m is selected from the group consisting of H, (C 1 -C 8 )alkyl, aryl, OH and SO 2 R n , wherein R n is selected from the group consisting of (C 1 -C 8 )alkyl, (C 1 -C 8 )haloalkyl, aryl(C 1 -C 8 )alkyl, (C 1 -C 8 )heteroalkyl, aryl, heteroaryl, (C 1 -C 8 )alkoxy, aryloxy, alkylamino, dialkylamino, arylamino, diarylamino, haloalkylamino and di(haloalkyl)amino, and R m and R c are optionally combined with the nitrogen atom to which each is attached to form a five- or six-membered ring;

HAr is selected from the group consisting of

optionally substituted with from one to three substituents independently selected from the group consisting of halogen, hydroxy, (C 1 -C 8 )alkyl, aryl(C 1 -C 8 )alkyl, (C 1 -C 8 )alkoxy, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )cycloalkyl, (C 4 -C 8 )cycloalkyl-alkyl, (C 1 -C 8 )heteroalkyl, (C 2 -C 5 )heterocyclyl, aryl, aryloxy, heterosubstituted(C 3 -C 7 )cycloalkyl, heteroalkyl substituted (C 3 -C 7 )cycloalkyl, (C 1 -C 8 )haloalkyl, O(C 1 -C 8 )haloalkyl, nitro, cyano, CO 2 R g , COR g , NR g R h , S(O) q R g , SO 2 NR g R h , NR g CONR h R i , NR g COR h , NR g COOR h and CONR g R h , wherein R g , R h and R i are each independently selected from the group consisting of H and (C 1 -C 8 )alkyl, or optionally two of R g , R h and R i when attached to the same nitrogen atom are combined to form a five- or six-membered ring, and the subscript q is an integer of from 0 to 2;

each R 1 and R 3 is a member independently selected from the group consisting of halogen, hydroxy, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )alkoxy, (C 3 -C 7 )cycloalkyl, (C 4 -C 8 )cycloalkyl-alkyl, (C 1 -C 8 )haloalkyl, (C 1 -C 8 )heteroalkyl, (C 2 -C 5 )heterocyclyl, heterosubstituted(C 3 -C 7 )cycloalkyl, heteroalkyl substituted (C 3 -C 7 )cycloalkyl, O(C 1 -C 8 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl, S(O) r -phenyl, COR j , COOR j , NR j R k , S(O) r R j , SO 2 NR j R k , NR j CONR k R l , NR j COR k , NR j COOR k and CONR j R k wherein the phenyl ring is optionally substituted and R j , R k and R l are each independently selected from the group consisting of H, (C 1 -C 8 )alkyl and (C 1 -C 8 )haloalkyl, or optionally two of R j , R k and R l when attached to the same nitrogen atom are combined to form a five- or six-membered ring, and the subscript r is an integer of from 0 to 2;

R 2 is a member selected from the group consisting of H, (C 1 -C 8 )alkyl, (C 1 -C 8 )haloalkyl, aryl(C 1 -C 8 )alkyl and (C 1 -C 4 )alkylene-Z, wherein Z is as defined above;

the subscript m is an integer of from 0 to 4;

the subscript p is an integer of from 0 to 3; and

pharmaceutically acceptable salts thereof.

2. A compound of claim 1 , wherein Y is selected from the group consisting of CH 2 OR c , CO 2 R c , tetrazol-5-yl, CONHSO 2 R n and CHO.

3. A compound of claim 1 , wherein Y is selected from the group consisting of CH 2 OR c , tetrazol-5-yl, CONHSO 2 R n and CO 2 R c .

4. A compound of claim 3 , wherein HAr is optionally substituted with from one to three substituents independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, aryl, aryloxy, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, CO 2 R g , COR 9 and CONR g R h .

5. A compound of claim 4 , wherein X is selected from the group consisting of O and S.

6. A compound of claim 5 , wherein R 2 is selected from the group consisting of H, CH 3 and CF 3 .

7. A compound of claim 6 , wherein HAr is attached to the 2- or 3-position of the ring bearing X and, is optionally substituted with from one to three substituents independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, CO 2 R g , COR g and CONR g R h .

8. A compound of claim 7 , wherein the subscript m is an integer of from 0 to 2, and each R 3 when present is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

9. A compound of claim 8 , wherein p is an integer of from 0 to 2 and each R 1 when present is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

10. A compound of claim 1 , wherein m is an integer of from 0 to 2; each R 3 when present is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl; p is an integer of from 0 to 2; and each R 1 is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

11. A compound of claim 7 , of the formula selected from the group consisting of:

wherein the subscript m is an integer of from 0 to 2, the subscript p is an integer of from 0 to 2, and R 1 and R 3 are each independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl; and R n is selected from the group consisting of (C 1 -C 8 )alkyl, (C 1 -C 8 )haloalkyl, aryl(C 1 -C 8 )alkyl, (C 1 -C 8 )heteroalkyl, aryl, heteroaryl, (C 1 -C 8 )alkoxy, aryloxy, alkylamino, dialkylamino, arylamino, diarylamino, haloalkylamino and di(haloalkyl)amino.

12. A compound of claim 11 , wherein R 2 is H or CH 3 ; the subscript m is 0 or 1, and p is 1 or 2; and R 1 and R 3 are each independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro and cyano.

13. A composition comprising a pharmaceutically acceptable excipient and a compound in accordance with claim 1 .

14. A composition in accordance with claim 13 , wherein Y is selected from the group consisting of CH 2 OR c , CO 2 R c , tetrazol-5-yl, CONHSO 2 R n and CHO.

15. A composition in accordance with claim 14 , wherein Y is selected from the group consisting of CH 2 OR c , tetrazol-5-yl, CONHSO 2 R n and CO 2 R c .

16. A composition in accordance with claim 15 , wherein HAr is optionally substituted with from one to three substituents independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, aryl, aryloxy, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O (C 1 -C 4 )haloalkyl, nitro, cyano, CO 2 R g , COR g and CONR g R h .

17. A composition in accordance with claim 16 , wherein X is selected from the group consisting of O and S.

18. A composition in accordance with claim 17 , wherein R 2 is selected from the group consisting of H, CH 3 and CF 3 .

19. A composition in accordance with claim 18 , wherein HAr is attached to the 2- or 3-position of the ring bearing X and is optionally substituted with from one to three substituents independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, CO 2 R g , COR g and CONR g R h .

20. A composition in accordance with claim 19 , wherein m is from 0 to 2; and each R 3 when present is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

21. A composition in accordance with claim 20 , wherein p is from 0 to 2; and each R 1 when present is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

22. A composition in accordance with claim 13 , wherein m is an integer of from 0 to 2; each R 3 is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl; p is an integer of from 0 to 2; and each R 1 is independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl.

23. A composition in accordance with claim 19 , wherein the compound has the formula selected from the group consisting of:

wherein the subscript m is an integer of from 0 to 2; the subscript p is an integer of from 0 to 2;

R 1 and R 3 are each independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, phenyl, O-phenyl, NR j -phenyl and S(O) r -phenyl; and R n is selected from the group consisting of (C 1 -C 8 )alkyl, (C 1 -C 8 )haloalkyl, aryl(C 1 -C 8 )alkyl, (C 1 -C 8 )heteroalkyl, aryl, heteroaryl, (C 1 -C 8 )alkoxy, aryloxy, alkylamino, dialkylamino, arylamino, diarylamino, haloalkylamino and di(haloalkyl)amino.

24. A composition in accordance with claim 23 , wherein HAr is optionally substituted with from one to three substituents independently selected from the group consisting of halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, O(C 1 -C 4 )haloalkyl, nitro, cyano, CO 2 R g , COR g and CONR g R h .

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME Recorded Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0491 →
DOCUMENT PREVIOUSLY RECORDED AT REEL 022973 FRAME 0618 CONTAINED ERRORS IN PATENT APPLICATION NUMBER 11/325,616. DOCUMENT RERECORDED TO CORRECT ERRORS ON STATED REEL. Recorded Nov 2, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 023460/0748 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CON Recorded Jul 16, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022973/0618 →
LICENSE Recorded Jun 17, 2009
From: METABOLEX, INC.
To: DIATEX, INC.
Reel/Frame 022835/0388 →
Continuity (3)
Continuation 1039448700 · Mar 19, 2003
Provisional Application 6036696100 · Mar 20, 2002
Related Publication 20060264630A1 · Nov 23, 2006